World Uro-Gynecological Surgical Devices Market

World Uro-Gynecological Surgical Devices Market

This report analyzes the worldwide markets for Uro-Gynecological Surgical Devices in US$ Million. The major product segments analyzed are Urological Surgical Devices (Sling & Suspension Devices, & Other Urological Devices), and Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, & Other Gynecological Devices). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia–Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. The report profiles 66 companies including many key and niche players worldwide such as Gyrus ACMI Corporation, American Medical Systems Holdings Incorporated, Laserscope, Inc., Boston Scientific Corporation, C. R. Bard, Inc., Cook Urological Inc., CooperSurgical, Inc., Cytyc Corporation, Cytyc Surgical Products, Ethicon Inc., Karl Storz GmbH & Co. KG, MDMI Technologies, Inc., Medtronic, Inc., Olympus America Inc., Olympus Surgical & Industrial America, Inc., Richard Wolf GmbH, and Stryker Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

URO-GYNECOLOGICAL SURGICAL DEVICES MCP-1554
A GLOBAL STRATEGIC BUSINESS REPORT


CONTENTS


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-2
Product Definitions and Scope of Study I-3
Urological Surgical Devices I-3
Sling & Suspension Devices I-3
Other Urological Devices I-4
Gynecological Surgical Devices I-4
Endometrial Ablation Devices I-4
Endoscopes I-4
Hysteroscope Systems I-4
Fluid Management Systems I-4
Other Gynecological Devices I-4


II. EXECUTIVE SUMMARY

1. Industry Overview II-1
Market Outlook II-1
Female Demographics & Gynecological Concerns II-1
Table 1: Percentage Breakdown of Total Female Population
Worldwide for Year 2005 (Based on Age Group) (includes
corresponding Graph/Chart) II-2

Table 2: Ovarian Cancer: Global Comparison of Incidence &
Mortality Rates by Select Countries (Number per 100,000
women) (includes corresponding Graph/Chart) II-2

Table 3: Uterus Cancer: Global Comparison of Incidence &
Mortality Rates by Select Countries (Number per 100,000
population) (includes corresponding Graph/Chart) II-3

Table 4: Cervical Cancer: Global Comparison of Incidence &
Mortality Rates by Select Countries (Number per 100,000
population) (includes corresponding Graph/Chart) II-3
Market Trends & Issues II-4
Demand to Enhance with Minimally Invasive Procedures II-4
Endometrial Ablation Devices Gaining Prominence II-4
Enhancing Market for Urological Surgical Devices II-4
Increasing R&D Efforts by Manufacturers II-4
Regulatory Risk - A Concern for Medical Device Companies II-5
Slower Recovery for Older Patients II-5

2. Product Overview II-6
Urological Surgical Devices II-6
Sling & Suspension Devices II-6
Other Urological Surgical Devices II-6
Ureteral Stents II-6
Gynecological Surgical Devices II-6
Endometrial Ablation Devices II-6
Endoscopes II-7
Laparoscope II-7
Cystoscope II-7
Falloposcope II-7
Hysteroscope Systems II-7
Fluid Management Systems II-7
Trocar II-8
Tubal Occlusion Systems II-8
Curettage Systems II-8
Female Pelvic Organs: Select Surgical Procedures II-8
Hysteroscopy Procedure II-8
Laparoscopy Procedure II-9
Dilation & Curettage (D&C) Procedure II-10
Hysterectomy Procedure II-10
Myomectomy Procedure II-12
Tubal Patency Screening Procedure II-12
Tubal Ligation Procedure II-13
Urethroscopy/Ureteroscopy II-13
Electrosurgery II-13
A Peek into Women’s Pelvic Health: Surgical Treatments II-13
Endometrial Ablation II-13
Benign-Caused Menorrhagia: Uterine Balloon Therapy (UBT) II-14
Urinary Incontinence II-15
Pelvic Organ Prolapse II-16

3. Recent Industry Activity II-18
Caldera Gains Rights to Coloplast’s Transobturator Technology II-18
Cytyc Merges with Hologic II-18
Mistral Pharma and CliniMed Sign Licensing Agreement II-18
Cook Medical Forms Distribution Partnership with Gynecor II-18
American Medical Systems Divests its Laserscope Aesthetics
Business II-18
Medtronic Initiates Post-Market Study of InterStim TherapyII
-18 Cytyc Corporation Acquires Adiana II-19
Aragon Acquires VeriSure, Inc. II-19
Cytyc Corporation Acquires Endometriosis Treatment Device from
Helica II-19
Teleflex Acquires Taut’s Assets II-20
Conceptus Inks Partnerships with Hysteroscope Producers II-20
Olympus & Conceptus Ally to Promote Hysteroscopes for Essure® II-20
Vision Sciences & Medtronic Terminate Urology Products
Distribution Agreement II-20
Synovis Inks Distribution Agreement with Caldera for Hydrix XM II-21
AMS Acquires Laserscope II-21
C. R. Bard Takes Over Venetec International II-21
ETHICON Acquires Vascular Control Systems II-22
AMS Purchases Urology Technology of BioControl Medical II-22
Laserscope Takes Over InnovaQuartz, Inc. II-22
ACMI Corporation Signs an Agreement with MMS II-22
AMS Forms Cross-Licensing Deal with Caldera Medical II-23
Mentor Divests Urology Business II-23
Gyrus Group Acquires ACMI II-23
C. R. Bard Acquired Select Assets from Genyx Medical II-23
Caldera Medical Forms Alliance with MTF II-23
Conceptus Signs Partnership Agreements II-24
Uroplasty Receives Approval for Urgent® PC Urological Device II-24
Uroplasty Receives USFDA Approval II-24
Cooper Surgical Steps into Gynecologic Surgery Market II-24
Conceptus Terminates Deal Signed with Gynecare II-25
Cytyc Corporation Acquires Novacept II-25
AMS Acquires CryoGen II-25

4. Product Innovations/Introductions II-26
Gyrus ACMI Launches New Endoscope Protection System II-26
Aragon Surgical Introduces a New LapCap Laparoscopic Device II-26
American Medical Systems Introduces MiniArc™ System II-26
Gyrus ACMI Unveils DUR-D Digital Flexible Ureteroscope II-26
Ethicon Launches GYNECARE TVT SECUR™ System for SUI Treatment II-27
Ethicon Unveils GYNECARE MORCELLEX Tissue Morcellator Device II-27
Medtronic Gains FDA & CE Mark Approvals for its InterStim® II
System II-27
FDA Approves Use of Ethicon’s Harmonic Wave for Open Surgical
Procedures II-28
Caldera Adds New Prolapse Indication for T-Sling II-28
FDA Approves Colpexin Sphere Device for Prolapse Support II-28
Laserscope Unveils GreenLight HPS II-28
New Mini-Hysteroscope from Blue Endo II-29
POPmesh™ from Caldera Medical II-29
Olympus Introduces New Endoscopes II-29
All-Digital Flexible Endoscope from ACMI II-29

5. Focus on Select Key Players II-30
Gyrus ACMI Corporation (USA) II-30
American Medical Systems Holdings Incorporated (USA) II-30
Laserscope, Inc. (USA) II-30
Boston Scientific Corporation (USA) II-31
C. R. Bard, Inc. (USA) II-32
Cook Urological Inc. (USA) II-32
CooperSurgical, Inc. (USA) II-32
Cytyc Corporation (USA) II-32
Cytyc Surgical Products II-33
Ethicon Inc. (USA) II-33
Karl Storz GmbH & Co. KG (Germany) II-33
MDMI Technologies, Inc. (Canada) II-33
Medtronic, Inc. (USA) II-34
Olympus America Inc. (USA) II-34
Olympus Surgical & Industrial America, Inc. (USA) II-34
Richard Wolf GmbH (Germany) II-35
Stryker Corporation (USA) II-35

6. Global Market Perspective II-36
Table 5: World Recent Past, Current and Future Analysis for
Uro-Gynecological Surgical Devices by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets Independently Analyzed by Annual Sales
in US$ Million for the Years 2001 through 2010 (includes
corresponding Graph/Chart) II-36

Table 6: World Long-term Projections for Uro-Gynecological
Surgical Devices by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed by Annual Sales in US$ Million
for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-37

Table 7: World 10-Year Perspective for Uro-Gynecological
Surgical Devices by Geographic Region - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia Pacific
(excluding Japan), and Rest of World Markets for the Years
2003, 2008 and 2012 (includes corresponding Graph/Chart) II-38

Table 8: World Recent Past, Current and Future Analysis for
Urological Surgical Devices by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed by Annual Sales in US$
Million for the Years 2001 through 2010 (includes
corresponding Graph/Chart) II-39

Table 9: World Long-term Projections for Urological Surgical
Devices by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed by Annual Sales in US$ Million for
Years 2011 through 2015 (includes corresponding Graph/Chart) II-40

Table 10: World 10-Year Perspective for Urological Surgical
Devices by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia Pacific (excluding
Japan), and Rest of World Markets for the Years 2003, 2008 and
2012 (includes corresponding Graph/Chart) II-41

Table 11: World Recent Past, Current and Future Analysis for
Urological Surgical Devices by Product Segment- Sling &
Suspension Devices and Other Urological Devices Markets
Independently Analyzed by Annual Sales in US$ Million for the
Years 2001 through 2010 (includes corresponding Graph/Chart) II-42

Table 12: World Long-term Projections for Urological Surgical
Devices by Product Segment - Sling & Suspension Devices and
Other Urological Devices Markets Independently Analyzed by
Annual Sales in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) II-42

Table 13: World 10-Year Perspective for Urological Surgical
Devices by Product Segment- Sling & Suspension Devices and
Other Urological Devices Markets for the Years 2003, 2008 and
2012 II-43

Table 14: World Recent Past, Current and Future Analysis for
Sling & Suspension Devices by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed by Annual Sales in US$
Million for the Years 2001 through 2010 (includes
corresponding Graph/Chart) II-44

Table 15: World Long-term Projections for Sling & Suspension
Devices by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed by Annual Sales in US$ Million for
Years 2011 through 2015 (includes corresponding Graph/Chart) II-45

Table 16: World 10-Year Perspective for Sling & Suspension
Devices by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia Pacific (excluding
Japan), and Rest of World Markets for the Years 2003, 2008 and
2012 (includecorresponding Graph/Chart) II-46

Table 17: World Recent Past, Current and Future Analysis for
Other Urological Devices by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed by Annual Sales in US$
Million for the Years 2001 through 2010 (includes
corresponding Graph/Chart) II-47

Table 18: World Long-term Projections for Other Urological
Devices by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed by Annual Sales in US$ Million for
Years 2011 through 2015 (includes corresponding Graph/Chart) II-48

Table 19: World 10-Year Perspective for Other Urological
Devices by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia Pacific (excluding
Japan), and Rest of World Markets for the Years 2003, 2008 and
2012 (includes corresponding Graph/Chart) II-49

Table 20: World Recent Past, Current and Future Analysis for
Gynecological Surgical Devices by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets Independently Analyzed by Annual Sales
in US$ Million for the Years 2001 through 2010 (includes
corresponding Graph/Chart) II-50

Table 21: World Long-term Projections for Gynecological
Surgical Devices by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed by Annual Sales in US$ Million
for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-51

Table 22: World 10-Year Perspective for Gynecological Surgical
Devices by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia Pacific (excluding
Japan), and Rest of World Markets for the Years 2003, 2008 and
2012 (includes corresponding Graph/Chart) II-52

Table 23: World Recent Past, Current and Future Analysis for
Gynecological Surgical Devices by Product Segment- Endometrial
Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid
Management Systems, and Other Gynecological Devices Markets
Independently Analyzed by Annual Sales in US$ Million for the
Years 2001 through 2010 (includes corresponding Graph/Chart) II-53

Table 24: World Long-term Projections for Gynecological
Surgical Devices by Product Segment- Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices Markets Independently
Analyzed by Annual Sales in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) II-53

Table 25: World 10-Year Perspective for Gynecological Surgical
Devices by Product Segment- Endometrial Ablation Devices,
Endoscopes, Hysteroscope Systems, Fluid Management Systems,
and Other Gynecological Devices Markets for the Years 2003,
2008 and 2012 (includes corresponding Graph/Chart) II-54

Table 26: World Recent Past, Current and Future Analysis for
Endometrial Ablation Devices by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets Independently Analyzed by Annual Sales
in US$ Million for the Years 2001 through 2010 (includes
corresponding Graph/Chart) II-55

Table 27: World Long-term Projections for Endometrial Ablation
Devices by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed by Annual Sales in US$ Million for
Years 2011 through 2015 (includes corresponding Graph/Chart) II-56

Table 28: World 10-Year Perspective for Endometrial Ablation
Devices by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe,Asia Pacific (excluding
Japan), and Rest of World Markets for the Years 2003, 2008 and
2012 (includes corresponding Graph/Chart) II-57

Table 29: World Recent Past, Current and Future Analysis for
Endoscopes by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed by Annual Sales in US$ Million for the
Years 2001 through 2010 (includes corresponding Graph/Chart) II-58

Table 30: World Long-term Projections for Endoscopes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed by Annual Sales in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) II-59

Table 31: World 10-Year Perspective for Endoscopes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia Pacific (excluding Japan), and
Rest of World Markets for the Years 2003, 2008 and 2012
(includes corresponding Graph/Chart) II-60

Table 32: World Recent Past, Current and Future Analysis for
Hysteroscope Systems by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed by Annual Sales in US$ Million
for the Years 2001 through 2010 (includes corresponding
Graph/Chart) II-61

Table 33: World Long-term Projections for Hysteroscope Systems
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed by Annual Sales in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) II-62

Table 34: World 10-Year Perspective for Hysteroscope Systems
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Canada, Japan, Europe, Asia Pacific (excluding Japan),
and Rest of World Markets for the Years2003, 2008 and 2012
(includes corresponding Graph/Chart) II-63

Table 35: World Recent Past, Current and Future Analysis for
Fluid Management Systems by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed by Annual Sales in US$
Million for the Years 2001 through 2010 (includes
corresponding Graph/Chart) II-64

Table 36: World Long-term Projections for Fluid Management
Systems by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed by Annual Sales in US$ Million for
Years 2011 through 2015 (includes corresponding Graph/Chart) II-65

Table 37: World 10-Year Perspective for Fluid Management
Systems by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia Pacific (excluding
Japan), and Rest of World Markets for the Years 2003, 2008 and
2012 (includes corresponding Graph/Chart) II-66

Table 38: World Recent Past, Current and Future Analysis for
Other Gynecological Devices by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed by Annual Sales in US$
Million for the Years 2001 through 2010 (includes
corresponding Graph/Chart) II-67

Table 39: World Long-term Projections for Other Gynecological
Devices by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed by Annual Sales in US$ Million for
Years 2011 through 2015 (includes corresponding Graph/Chart) II-68

Table 40: World 10-Year Perspective for Other Gynecological
Devices by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia Pacific (excluding
Japan), and Rest of World Markets for the Years 2003, 2008 and
2012 (includes corresponding Graph/Chart) II-69


III. MARKET

1. The United States III-1
A.Market Analysis III-1
Female Demographics III-1
Table 41: Percentage Breakdown of Female Population in the
US by Age Group: 2007 (includes corresponding Graph/Chart) III-1
Current Scenario in the US Gynecological Devices Market III-1
Table 42: Number of GEA Procedures (2005-2007) in the US
(includes corresponding Graph/Chart) III-2
Major Trends & Issues III-2
Increasing Acceptance of Alternative Procedures to
Hysterectomy III-2
Bright Prospects for Urological Surgical Devices III-2
Least-Invasive Surgical Procedures Drive the US Market III-3
Demographics to Play a Major Role III-3
Table 43: Prevalence of Various Urological Disorders in
Females over 65 Years (includes corresponding Graph/Chart) III-3
Gynecological Disorders in US Women III-3
Table 44: Gynecological Cancer in the US: Incidence &
Mortality Rates of Various Cancersfor the Year 2005
(includes corresponding Graph/Chart) III-4

Table 45: Gynecological Cancer in the US: Number of New
Cancer Cases Diagnosed for the Year 2004 (includes
corresponding Graph/Chart) III-4

Table 46: Cervical Cancer in the US: Comparison of
Incidence & Mortality Rates by Select Race/Ethnicity for
Year 2002 (includes corresponding Graph/Chart) III-5

Table 47: Select Surgical Procedures Performed in the US
for the Year 2005 (Procedures in Thousand) III-5
Hysterectomy in the United States III-5
Major Reasons for Hysterectomy Procedures in the US (Based
on Age Group) III-6
Table 48: Hysterectomy Procedures in the US - Percentage
Breakdown by Causes/Disorders (includes corresponding
Graph/Chart) III-6

Table 49: US Recent Past, Current and Future Analysis for
Hysterectomy by Procedure Types - Abdominal Hysterectomy,
and Vaginal Hysterectomy Independently Analyzed by
Procedure Number in Thousand for the Years 2001 through
2010 (includes corresponding Graph/Chart) III-6

Table 50: US Recent Past, Current and Future Analysis for
Hysteroscopy by Procedure Types -Diagnostic Hysteroscopy,
and Operative Hysteroscopy Independently Analyzed by
Procedure Number in Thousand for the Years 2001 through
2010 (includes corresponding Graph/Chart) III-7
Glimpse of Medicare Reimbursements in the US III-7
Table 51: Medicare Reimbursements for Hysterectomy
Procedures for the Year 2005 III-7
Table 52: Medicare Reimbursements for Endometrial Ablation
Procedures for the Year 2005 III-8
Table 53: Medicare Reimbursements for Vaginal Vault Support
(AVESTA® Procedure) for the Year 2005 III-8
Table 54: Medicare Reimbursements for Uterine Suspension
(UPLIFT Procedure) for the Year 2005 III-9
Table 55: Medicare Reimbursements for Uterine Prolapse
Repair (ELEVEST® Procedure) for the Year 2005 III-9
Major Players III-9
Table 56: US Market for Sling Systems: Market Shares of
Major Players - Johnson & Johnson, American Medical
Systems, Boston Scientific Corporation, C.R. Bard, Inc,
Cook Urological Inc Mentor Corporation, and Others for the
Years 2004 & 2005 (includes corresponding Graph/Chart) III-10

Table 57: US Market for Suspension Systems: Market Shares
of Major Players - Boston Scientific Corporation, C.R.
Bard, Inc, CooperSurgical, Inc, and Others for the Years
2005 & 2006 (includes corresponding Graph/Chart) III-10

Table 58: US Market for Ablation Systems: Market Shares of
Major Players - American Medical Systems, Boston Scientific
Corporation, Johnson & Johnson, Microsulis, and Others for
the Years 2005 & 2006 (includes corresponding Graph/Chart) III-11

Table 59: US Market for Endoscopic Products: Market Shares
of Major Players - ACMI, Johnson & Johnson, Karl Storz
Endoscope-America, Inc, Richard Wolf Instruments, United
States Surgical, and Others for the Years 2005 & 2006
(includes corresponding Graph/Chart) III-11

Table 60: US Market for Hysteroscope Systems: Market Shares
of Major Players - ACMI, CooperSurgical, Inc, Johnson &
Johnson, and Others for the Years 2005 & 2006 (includes
corresponding Graph/Chart) III-12

Table 61: US Market for Fluid Management Systems: Market
Shares of Major Players - ACMI, American Medical Systems,
Johnson & Johnson, and Others for the Years 2005 & 2006
(includes corresponding Graph/Chart) III-12

Table 62: US Market for Other Gynecological Products:
Market Shares of Major Players - ACMI, American Medical
Systems, Boston Scientific Corporation, Cooper Surgical,
Inc, United States Surgical, and Others for the Years 2005
& 2006 (includes corresponding Graph/Chart) III-13
Select Products from Major US Companies in Respective
Market Segments III-13
Strategic Corporate Developments III-14
Product Launches III-21
Key Players III-25
B.Market Analytics III-30
Table 63: US Recent Past, Current and Future Analysis for
Uro-Gynecological Surgical Devices by Product Group/Segment
- Urological Surgical Devices (Sling & Suspension Devices,
and Other Urological Devices), Gynecological Surgical
Devices (Endometrial Ablation Devices, Endoscopes,
Hysteroscope Systems, Fluid Management Systems, and Other
Gynecological Devices) Markets Independently Analyzed by
Annual Sales in US$ Million for the Years 2001 through 2010
(includes corresponding Graph/Chart) III-30

Table 64: US Long-term Projections for Uro-Gynecological
Surgical Devices by Product Group/Segment - Urological
Surgical Devices (Sling & Suspension Devices, and Other
Urological Devices), Gynecological Surgical Devices
(Endometrial Ablation Devices, Endoscopes, Hysteroscope
Systems, Fluid Management Systems, and Other Gynecological
Devices) Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-31

Table 65: US 10-Year Perspective for Uro-Gynecological
Surgical Devices by Product Group/Segment - Percentage
Breakdown of Dollar Sales for Urological Surgical Devices
(Sling & Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets forthe
Years 2003, 2008 and 2012 (includes corresponding
Graph/Chart) III-32

2. Canada III-33
A.Market Analysis III-33
Market Overview III-33
Female Demographics III-33
Table 66: Percentage Breakdown of Female Population in
Canada by Age Group: 2006 (includes corresponding
Graph/Chart) III-33

Table 67: Number of New Gynecological Cancer Cases
Diagnosed in Canada in 2004 III-33
Strategic Corporate Development III-34
MDMI Technologies Inc. - A Key Player III-34
B.Market Analytics III-35
Table 68: Canadian Recent Past, Current and Future Analysis
for Uro-Gynecological Surgical Devices by Product
Group/Segment - Urological Surgical Devices (Sling &
Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets
Independently Analyzed by Annual Sales in US$ Million for
the Years 2001 through 2010 (includes corresponding
Graph/Chart) III-35

Table 69: Canadian Long-term Projections for
Uro-Gynecological Surgical Devices by Product Group/ Segment
- Urological Surgical Devices (Sling & Suspension Devices,
and Other Urological Devices), Gynecological Surgical
Devices (Endometrial Ablation Devices, Endoscopes,
Hysteroscope Systems, Fluid Management Systems, and Other
Gynecological Devices) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-36

Table 70: Canadian 10-Year Perspective for Uro-Gynecological
Surgical Devices by Product Group/ Segment - Percentage
Breakdown of Dollar Sales for Urological Surgical Devices
(Sling & Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets for the
Years 2003, 2008 and 2012 (includes corresponding
Graph/Chart) III-37

3. Japan III-38
A.Market Analysis III-38
Market Overview III-38
Female Demographics III-38
Table 71: Percentage Breakdown of Female Population in
Japan by Age Group: 2007 (includes corresponding
Graph/Chart) III-38
B.Market Analytics III-39
Table 72: Japanese Recent Past, Current and Future Analysis
for Uro-Gynecological Surgical Devices by Product
Group/Segment - Urological Surgical Devices (Sling &
Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets
Independently Analyzed by Annual Sales in US$ Million for
the Years 2001 through 2010 (includes corresponding
Graph/Chart) III-39

Table 73: Japanese Long-term Projections for
Uro-Gynecological Surgical Devices by Product Group/Segment
- Urological Surgical Devices (Sling & Suspension Devices,
and Other Urological Devices), Gynecological Surgical
Devices (Endometrial Ablation Devices, Endoscopes,
Hysteroscope Systems, Fluid Management Systems, and Other
Gynecological Devices) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-40

Table 74: Japanese 10-Year Perspective for Uro-Gynecological
Surgical Devices by Product Group/Segment - Percentage
Breakdown of Dollar Sales for Urological Surgical Devices
(Sling & Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems,Fluid Management
Systems, and Other Gynecological Devices) Markets for the
Years 2003, 2008 and 2012 (includes corresponding
Graph/Chart) III-41

4. Europe III-42
A.Market Analysis III-42
Market Overview III-42
Female Demographics III-42
Table 75: Percentage Breakdown of Total Female Population
of European Union for the Year 2005 (Based on Age Group)
(includes corresponding Graph/Chart) III-42

Table 76: Percentage Breakdown of Total Female Population
of European Union for the Year 2005 by Member Countries
(Based on Age Group) III-43
Gynecological Cancer Statistics III-43
Table 77: Mortality Rate of Cervical Cancer in Select
European Regions for the Year 2000 (Number per 100,000
women) (includes corresponding Graph/Chart) III-44
Current Scenario in the European Gynecological Devices Market III-44
B.Market Analytics III-45
Table 78: European Recent Past, Current and Future Analysis
for Uro-Gynecological Gynecological Devices by Geographic
Region - France, Germany, UK, Italy, and Rest of Europe
Markets Independently Analyzed by Annual Sales in US$
Million for the Years 2001 through 2010 (includes
corresponding Graph/Chart) III-45

Table 79: European Long-term Projections for
Uro-Gynecological Devices by Geographic Region - France,
Germany, UK, Italy, and Rest of Europe Markets Independently
Analyzed by Annual Sales in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-46

Table 80: European Recent Past, Current and Future Analysis
for Uro-Gynecological Surgical Devices by Product
Group/Segment - Urological Surgical Devices (Sling &
Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets
Independently Analyzed by Annual Sales in US$ Million for
the Years 2001 through 2010 (includes corresponding
Graph/Chart) III-47

Table 81: European Long-term Projections for
Uro-Gynecological Surgical Devices by Product Group/Segment
- Urological Surgical Devices (Sling & Suspension Devices,
and Other Urological Devices), Gynecological Surgical
Devices (Endometrial Ablation Devices, Endoscopes,
Hysteroscope Systems, Fluid Management Systems, and Other
Gynecological Devices) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-48

Table 82: European 10-Year Perspective for Uro-
Gynecological Devices by Geographic Region - Percentage
Breakdown of Dollar Sales for France, Germany, UK, Italy,
and Rest of Europe Markets for the Years 2003, 2008 and 2012
(includes corresponding Graph/Chart) III-49

Table 83: European 10-Year Perspective for Uro-Gynecological
Surgical Devices by Product Group / Segment - Percentage
Breakdown of Dollar Sales for Urological Surgical Devices
(Sling & Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets for the
Years 2003, 2008 and 2012 (includes corresponding
Graph/Chart) III-50

4a. France III-51
A.Market Analysis III-51
Market Overview III-51
Female Demographics III-51
Table 84: Percentage Breakdown of Female Population in
France by Age Group: 2007 (includes corresponding
Graph/Chart) III-51
Select Diagnostic Procedures Performed in France in 2005 III-51
B.Market Analytics III-52
Table 85: French Recent Past, Current and Future Analysis
for Uro-Gynecological Surgical Devices by Product
Group/Segment - Urological Surgical Devices (Sling &
Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets
Independently Analyzed by Annual Sales in US$ Million for
the Years 2001 through 2010 (includes corresponding
Graph/Chart) III-52

Table 86: French Long-term Projections for Uro-Gynecological
Surgical Devices by Product Group/ Segment - Urological
Surgical Devices (Sling & Suspension Devices, and Other
Urological Devices), Gynecological Surgical Devices
(Endometrial Ablation Devices, Endoscopes, Hysteroscope
Systems, Fluid Management Systems, and Other Gynecological
Devices) Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-53

Table 87: French 10-Year Perspective for Uro-Gynecological
Surgical Devices by Product Group/ Segment - Percentage
Breakdown of Dollar Sales for Urological Surgical Devices
(Sling & Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems,Fluid Management
Systems, and Other Gynecological Devices) Markets for the
Years 2003, 2008 and 2012 (includes corresponding
Graph/Chart) III-54

4b. Germany III-55
A.Market Analysis III-55
Market Overview III-55
Female Demographics III-55
Table 88: Percentage Breakdown of Female Population in
Germany by Age Group: 2007 (includes corresponding
Graph/Chart) III-55
Select Diagnostic Procedures Performed in Germany in 2005 III-55
Key Players III-55
B.Market Analytics III-56
Table 89: German Recent Past, Current and Future Analysis
for Uro-Gynecological Surgical Devices by ProductGroup/
Segment - Urological Surgical Devices (Sling & Suspension
Devices, and Other Urological Devices), Gynecological
Surgical Devices (Endometrial Ablation Devices, Endoscopes,
Hysteroscope Systems, Fluid Management Systems, and Other
Gynecological Devices) Markets Independently Analyzed by
Annual Sales in US$ Million for the Years 2001 through 2010
(includes corresponding Graph/Chart) III-56

Table 90: German Long-term Projections for Uro-Gynecological
Surgical Devices by Product Group/ Segment - Urological
Surgical Devices (Sling & Suspension Devices, and Other
Urological Devices), Gynecological Surgical Devices
(Endometrial Ablation Devices, Endoscopes, Hysteroscope
Systems, Fluid Management Systems, and Other Gynecological
Devices) Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-57

Table 91: German 10-Year Perspective for Uro- Gynecological
Surgical Devices by Product Group/ Segment - Percentage
Breakdown of Dollar Sales for Urological Surgical Devices
(Sling & Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets for the
Years 2003, 2008 and 2012 (includes corresponding
Graph/Chart) III-58

4c. The United Kingdom III-59
A.Market Analysis III-59
Market Overview III-59
Female Demographics III-59
Table 92: Percentage Breakdown of Female Population in the
UK for Year 2007 (Based on Age Group) (includes
corresponding Graph/Chart) III-59
Select Diagnostic Procedures Performed in the UK in 2005 III-59
UK Gynecological Cancer Market III-59
Table 93: Mortality Rates of Gynecological Cancer Cases in
the UK in 2004 III-60

Table 94: Number of Gynecological Cancer Cases Diagnosed in
the UK in 2002 (includes corresponding Graph/Chart) III-60
New UK NICE Clinical Guidelines Promote Endometrial Ablation
for HMB III-60
Embolisation - Ideal Alternative to Hysterectomy Procedures III-61
Strategic Corporate Developments III-61
Femcare-Nikomed Ltd - A Key Player III-62
B.Market Analytics III-63
Table 95: UK Recent Past, Current and Future Analysis for
Uro-Gynecological Surgical Devices by Product Group/ Segment
- Urological Surgical Devices (Sling & Suspension Devices,
and Other Urological Devices), Gynecological Surgical
Devices (Endometrial Ablation Devices, Endoscopes,
Hysteroscope Systems, Fluid Management Systems, and Other
Gynecological Devices) Markets Independently Analyzed by
Annual Sales in US$ Million for the Years 2001 through 2010
(includes corresponding Graph/Chart) III-63

Table 96: UK Long-term Projections for Uro- Gynecological
Surgical Devices by Product Group/ Segment - Urological
Surgical Devices (Sling & Suspension Devices, and Other
Urological Devices), Gynecological Surgical Devices
(Endometrial Ablation Devices, Endoscopes, Hysteroscope
Systems, Fluid Management Systems, and Other Gynecological
Devices) Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-64

Table 97: UK 10-Year Perspective for Uro- Gynecological
Surgical Devices by Product Group/Segment - Percentage
Breakdown of Dollar Sales for Urological Surgical Devices
(Sling & Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets for the
Years 2003, 2008 and 2012 (includes corresponding
Graph/Chart) III-65

4d. Italy III-66
A.Market Analysis III-66
Market Overview III-66
Female Demographics III-66
Table 98: Percentage Breakdown of Female Population in
Italy by Age Group: 2007 (includes corresponding
Graph/Chart) III-66
Select Diagnostic Procedures Performed in Italy in 2005 III-66
B.Market Analytics III-67
Table 99: Italian Recent Past, Current and Future Analysis
for Uro-Gynecological Surgical Devices by Product
Group/Segment - Urological Surgical Devices (Sling &
Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets
Independently Analyzed by Annual Sales in US$ Million for
the Years 2001 through 2010 (includes corresponding
Graph/Chart) III-67

Table 100: Italian Long-term Projections for
Uro-Gynecological Surgical Devices by Product Group/ Segment
- Urological Surgical Devices (Sling & Suspension Devices,
and Other Urological Devices), Gynecological Surgical
Devices (Endometrial Ablation Devices, Endoscopes,
Hysteroscope Systems, Fluid Management Systems, and Other
Gynecological Devices) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-68

Table 101: Italian 10-Year Perspective for Uro-Gynecological
Surgical Devices by Product Group/Segment - Percentage
Breakdown of Dollar Sales for Urological Surgical Devices
(Sling & SuspensionDevices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets for the
Years 2003, 2008 and 2012 (includes corresponding
Graph/Chart) III-69

4e. Rest of Europe III-70
Market Analysis III-70
Table 102: Rest of Europe Recent Past, Current and Future
Analysis for Uro-Gynecological Surgical Devices by Product
Group/Segment - Urological Surgical Devices (Sling &
Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets
Independently Analyzed by Annual Sales in US$ Million for
the Years 2001 through 2010 (includes corresponding
Graph/Chart) III-70

Table 103: Rest of Europe Long-term Projections for
Uro-Gynecological Surgical Devices by Product Group/Segment
- Urological Surgical Devices (Sling & Suspension Devices,
and Other Urological Devices), Gynecological Surgical
Devices (Endometrial Ablation Devices, Endoscopes,
Hysteroscope Systems, Fluid Management Systems, and Other
Gynecological Devices) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-71

Table 104: Rest of Europe 10-Year Perspective for
Uro-Gynecological Surgical Devices by Product Group /
Segment - Percentage Breakdown of Dollar Sales for
Urological Surgical Devices (Sling & Suspension Devices, and
Other Urological Devices), Gynecological Surgical Devices
(Endometrial Ablation Devices, Endoscopes, Hysteroscope
Systems, Fluid Management Systems, and Other Gynecological
Devices) Markets for the Years 2003, 2008 and 2012 (includes
corresponding Graph/Chart) III-72

5. Asia-Pacific III-73
A.Market Analysis III-73
Market Overview III-73
Table 105: Percentage Breakdown of Total Female Population
for Select Asian Countries for the Year 2007 (Based on Age
Group) III-73
Glance at Chinese and Indian Markets III-73
A Peek Into Australian Market III-74
Table 106: Incidence Rates of Gynecological Cancer in
Australia for the Year 2005 (includes corresponding
Graph/Chart) III-74

Table 107: Mortality Rates of Gynecological Cancer in
Australia for the Year 2004 (includes corresponding
Graph/Chart) III-74

Table 108: Risk of Developing Gynecological Cancer Among
Australian Women III-75
B.Market Analytics III-75
Table 109: Asia Pacific Recent Past, Current and Future
Analysis for Uro-Gynecological Surgical Devices by Product
Group/Segment - Urological Surgical Devices (Sling &
Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems, Fluid Management
Systems, and Other Gynecological Devices) Markets
Independently Analyzed by Annual Sales in US$ Million for
the Years 2001 through 2010 (includes corresponding
Graph/Chart) III-75

Table 110: Asia-Pacific Long-term Projections for
Uro-Gynecological Surgical Devices by Product Group/ Segment
- Urological Surgical Devices (Sling & Suspension Devices,
and Other Urological Devices), Gynecological Surgical
Devices (Endometrial Ablation Devices, Endoscopes,
Hysteroscope Systems, Fluid Management Systems, and Other
Gynecological Devices) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-76

Table 111: Asia Pacific 10-Year Perspective for
Uro-Gynecological Surgical Devices by Product Group/ Segment
- Percentage Breakdown of Dollar Sales for Urological
Surgical Devices (Sling & Suspension Devices, and Other
Urological Devices), Gynecological Surgical Devices
(Endometrial Ablation Devices, Endoscopes, Hysteroscope
Systems, Fluid Management Systems, and Other Gynecological
Devices) Markets for the Years 2003, 2008 and 2012
(includes corresponding Graph/Chart) III-77

6. Rest of World III-78
A.Market Analysis III-78
Strategic Corporate Developments III-78
B.Market Analytics III-79
Table 112: Rest of World Recent Past, Current and Future
Analysis for Uro-Gynecological Surgical Devices by Product
Group/Segment - Urological Surgical Devices (Sling &
Suspension Devices, and Other Urological Devices),
Gynecological Surgical Devices (Endometrial Ablation
Devices, Endoscopes, Hysteroscope Systems,Fluid Management
Systems, and Other Gynecological Devices) Markets
Independently Analyzed by Annual Sales in US$ Million for
the Years 2001 through 2010 (includes corresponding
Graph/Chart) III-79

Table 113: Rest of World Long-term Projections for
Uro-Gynecological Surgical Devices by Product Group/Segment
- Urological Surgical Devices (Sling & Suspension Devices,
and Other Urological Devices), Gynecological Surgical
Devices (Endometrial Ablation Devices, Endoscopes,
Hysteroscope Systems, Fluid Management Systems, and Other
Gynecological Devices) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-80

Table 114: Rest of World 10-Year Perspective for
Uro-Gynecological Surgical Devices by Product Group /Segment
- Percentage Breakdown of Dollar Sales for Urological
Surgical Devices (Sling & Suspension Devices, and Other
Urological Devices), Gynecological Surgical Devices
(Endometrial Ablation Devices, Endoscopes, Hysteroscope
Systems, Fluid Management Systems, and Other Gynecological
Devices) Markets for the Years2003, 2008 and 2012 (includes
corresponding Graph/Chart) III-81


IV. COMPETITIVE LANDSCAPE